MedPath

Comparative Evaluation Of Locally Delivered Gels Adjunct To Scaling And Root Planing

Phase 4
Conditions
Health Condition 1: R52- Pain, unspecified
Registration Number
CTRI/2024/05/067060
Lead Sponsor
Asmita Ghanti
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Chronic Periodontitis patient without any systemic disease.

2.Adults in age group of 35 to 65 years.

3.Two or more teeth having a periodontal pocket depth of 4-6 mm and Clinical Attachment Loss of greater than 3mm on both quadrants of same arch.

Exclusion Criteria

1. Patients having habit of chewing pan, tobacco chewing/smoking habits.

2.Use of antibiotics in previous three months.

3.Allergy to Metronidazole and Chlorhexidine.

4.Patient who received active periodontal treatment within 6 months.

5.Physically challenged patients having other health issues

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Metronidazole gel - Change or no change <br/ ><br>2.Combination of Metronidazole and Chlorhexidine gel- change or no changeTimepoint: baseline vist, after 15 days, 1 month, 3 month,6months and 9 months
Secondary Outcome Measures
NameTimeMethod
1.Metronidazole gel - Change or no change <br/ ><br>2.Combination of Metronidazole & Chlorhexidine gel- change or no changeTimepoint: baseline vist, after 15 days, 1 month, 3 month,6months & 9 months
© Copyright 2025. All Rights Reserved by MedPath